Amid incidents of toxic cough syrups, the organization has called on countries and regulators to strengthen action against the threat of substandard and falsified medical products.
Pfizer sees all-time high for 2022 revenues; but declining COVID-19 products market will hit 2023 sales
from BioPharma-Reporter.com
BioNTech completes first in-house plasmid DNA manufacturing facility
from BioPharma-Reporter.com
New US CDMO launched to address viral vector supply bottleneck
from BioPharma-Reporter.com
Prothena: Trial data underscores the potential of antibody in treating Alzheimer’s disease
from BioPharma-Reporter.com
A shift in balance to hybrid trials 'could be the Holy Grail' says patient services VP
Patient centricity
Asthma treatment approved by FDA after success of trial program
Consolidation
Bioethics International reveals index to score pharma on trial diversity
Patient centricity
How blockchain could improve data management in healthcare supply chains
Clinical evolution
Biolog adds contract microbial service capabilities through MIDI Labs buyout
Mergers and Acquisitions
FDA approves licence for anti-amyloid drug to treat Alzheimer's disease
